FGF23 and myeloid sarcoma: The main aim of this study was to further elucidate the vitamin D-FGF23 axis by measuring multiple D metabolites and FGF23 using accurate state-of-the art analytical methods in a well-defined cohort of MS patients versus healthy controls.